Artificial intelligence is rapidly reshaping the way biopharma companies discover, develop, and manufacture medicines. H...
RoosterBio and Qkine have entered a distribution agreement to provide U.S. customers with a single-source platform for c...
Catalent and Nanoscope Therapeutics have expanded their partnership to support late-phase clinical development and comme...
FibroBiologics has completed manufacturing of the third batch of CYWC628 drug product for its ongoing Phase 1/2 clinical...
Insilico Medicine has initiated a Phase III clinical trial of rentosertib, its AI-discovered oral small-molecule TNIK in...
REPROCELL has submitted an application for manufacturing and marketing approval in Japan for Stemchymal, a regenerative ...
As cell and gene therapies progress from promising research to commercial reality, manufacturing has emerged as ...
The rapid expansion of in vivo gene therapy is reshaping expectations for viral vector manufacturing, placing greater em...
UniXell Biotechnology has received U.S. FDA Investigational New Drug clearance for UX-DA003, its allogeneic induced plur...
The Australian government is providing more than $15 million to Monash University and Atisama Therapeutics to revolution...
Despite causing millions of serious infections and hundreds of thousands of deaths each year, fungal diseases continue t...
During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...
As obesity treatment enters a new phase of innovation, the industry is increasingly looking beyond GLP-1 therapies to ad...
As obesity treatment evolves beyond weight loss toward comprehensive cardiometabolic disease management, pharmaceutical ...
China-based Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with US-based...
Few therapeutic areas have witnessed the level of progress achieved in HIV over the past three decades...
Artificial intelligence has long promised to transform healthcare, yet widespread adoption has often been hindered by ch...
Lys Therapeutics has raised more than €25 million since its founding in 2021 to advance LYS241, its lead neurovascu...
Phanes Therapeutics has completed enrolment in its Phase II study of spevatamig in combination with standard-of-care che...
AnHorn Medicines has received U.S. FDA Investigational New Drug clearance and Taiwan Center for Drug Evaluation Index Ca...
Autoimmune and inflammatory diseases frequently affect the eye, yet ophthalmology has largely remained on the sidelines ...
The search for safer and more effective pain therapies remains one of medicine's most pressing challenges. Despite advan...
As artificial intelligence reshapes the future of genomic medicine, WhiteLab Genomics is positioning itself at t...
Artificial intelligence is rapidly transforming biologics discovery, but the industry's focus is shifting from generatin...
Despite decades of advances in oncology, many solid tumours remain difficult to treat effectively without exposing patie...
